Skip to main content
Home
Toggle menu

Give Now

  • For Patients
  • School Of Medicine
  • About
    • Leadership
    • Department Directory
    • News
    • Events
    • Annual Report
    • Nashville
  • Divisions
    • Allergy, Pulmonary and Critical Care Medicine
    • Cardiovascular Medicine
    • Diabetes, Endocrinology and Metabolism
    • Epidemiology
    • Gastroenterology, Hepatology and Nutrition
    • General Internal Medicine and Public Health
    • Genetic Medicine and Clinical Pharmacology
    • Geriatric Medicine
    • Hematology and Oncology
    • Infectious Diseases
    • Nephrology and Hypertension
    • Rheumatology and Immunology
  • Education
    • Overview
    • Internal Medicine Residency Program
    • Physician-Scientist Training Program
    • Internal Medicine-Pediatrics Residency Program
    • Fellowship Programs
    • EXCellence In TEaching Pathway
    • Physician-Scientist Doctoral Program
    • Medical Students
    • Alumni
    • Medicine Grand Rounds
  • Research
    • Overview
    • Clinical Trials
    • Publications
    • Research Centers and Labs
  • Faculty
    • Open Faculty Positions
    • Professional Development
  • Clinical Initiatives
    • Digital Health
    • Physician Builder Program

User Detail

MacRae Linton, MD

Professor of Medicine

Division of Cardiovascular Medicine

Dr. Stephen J. Schillig, Jr. and Mary Schillig Chair in Medicine

Director, Prevention and Lipid Management Program

MacRae Linton
Professional Bio
MacRae F. Linton, MD, is a Professor of Medicine and director of the Atherosclerosis Research Unit in the Division of Cardiovascular Medicine in the Department of Medicine at Vanderbilt University Medical Center. His research programs involve basic science and clinical translational investigations of inherited disorders of cholesterol/lipoprotein metabolism, macrophage biology, and atherosclerosis. Dr. Linton pioneered the use of bone marrow transplantation (BMT) as an approach to investigate the impact of genes expressed by bone marrow-derived cells, including macrophages, on the development of atherosclerosis in mouse models. This initial work demonstrated the ability of macrophage expression of apoE to serve as a vehicle for gene therapy for atherosclerosis. Subsequent studies have investigated genes important in the macrophage's role in inflammation, efferocytosis, and autophagy. Dr. Linton is currently the Principal Investigator of an NHLBI-funded program project grant on HDL function in human disease. He has also served as the PI of several clinical trials of cholesterol lowering drugs and cardiovascular outcomes studies at Vanderbilt, including recent trials of PCSK9 inhibitors and the ongoing HORIZON trial, evaluating the ability of lowering Lipoprotein(a) with an anti-sense oligonucleotide to reduce cardiovascular events. Dr. Linton has published more than 230 peer-reviewed papers, many of them in high impact journals, and he has had continuous NIH funding for his research for more than 28 years. His research has been recognized by numerous awards including the Irvine H. Page Young Investigator Award for Atherosclerosis Research from the American Heart Association, the Presidential Early Career Award for Scientists and Engineers, the Elliott Newman Prize for Basic Research, and the Goodpasture Faculty Award at Vanderbilt. He has been elected to the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP), and as a fellow of the American Association for the Advancement of Science (AAAS). Dr. Linton is the director of the Vanderbilt Lipid Clinic, which he founded in 1994. The VLC has become an established regional referral service for patients with hypercholesterolemia and increased coronary risk. He developed the LDL Apheresis program at Vanderbilt with the Dialysis Center for management of patients with severe hypercholesterolemia in 2003. He was designated one of America's Top Doctors, Cardiovascular Disease, by Castle Connolly/U.S. News (2008-present).
Relevant Links
Provider Profile
Publications
View Publications

Education

MD - University of Tennessee Health Science Center, 1985

Internship - Internal Medicine - Vanderbilt University, 1986

Residency - Internal Medicine - Vanderbilt University, 1988

Fellowship - Endocrinology/Metabolism - University of California, San Francisco, 1991

Contact

Email 
Kimryn.Rathmell@Vumc.Org 
Address 
777 Preston Research Building 
2220 Pierce Ave 
Nashville, TN 37232-6307

Submitted by admin on Thu, 06/01/2023 - 04:28

1161 21st Ave S
Nashville, TN 37232

(615) 322-5000

Quick Links

  • Home
  • About
  • Divisions
  • Education
  • Research
  • Faculty
  • Intranet

Support Our Work

Start a fundraiser or donate to the Department of Medicine.

Give Now

Vanderbilt Health is committed to fostering an environment where everyone has the chance to thrive and is committed to the principles of equal opportunity. EOE/Vets/Disabled.

Copyright © Vanderbilt University Medical Center

sfy39587stp18